References
- World Health OrganizationLeprosy update, 2011Wkly Epidemiol Rec2011863638940021887885
- Ministério da SaúdeCoordenação Geral do Programa Nacional de Controle da Hanseníase – CGPNCHHansen’s Disease Control National ProgramBrasíliaMinistério da Saúde2011 Available from: http://www.google.ca/url?sa=t&rct=j&q=&esrc=s&frm=1&source=web&cd=1&ved=0CCMQFjAA&url=http%3A%2F%2Fwww.ilep.org.uk%2Ffileadmin%2Fuploads%2FCountry_Pages%2FBrazil%2FReport_NHDCP_2011_web.pdf&ei=AEl6UKO0E6azyQG8iYDQAg&usg=AFQjCNEbaMFiccRpuCOrBiBcuhHs8D1iMg&sig2=de23c3KFH09VSRJ6R2a7pg&cad=rjaAccessed October 12, 2012 Portuguese
- FernandezJMThe early reaction induced by leprominInt J Lepr Other Mycobact Dis19408114
- StanleySJHowlandCStoneMMSutherlandIBCG vaccination of children against leprosy in Uganda: final resultsJ Hyg (Lond)19818722332487288177
- GupteMDField trials of antileprosy vaccinesIndian J Lepr199870436336710189586
- LwinKSudaresanTGyiMMBCG vaccination of children against leprosy: fourteen-year findings of the trial in BurmaBull World Health Organ1985636106910782940028
- BagshaweAScottGCRusselDAWingleySCMerianosABerryGBCG vaccination in leprosy: final results of the trial in Karimui, Papua New Guinea, 1963–1979Bull World Health Organ19896743893992680140
- ZodpeySPProtective effect of bacillus Calmette Guerin (BCG) vaccine in the prevention of leprosy: a meta-analysisIndian J Dermatol Venereol Leprol2007732869317456912
- NarangTKaurIKumarBRadotraBDDograSComparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosyInt J Lepr Other Mycobact Dis200573210511416830653
- RidleyDSJoplingWHClassification of leprosy according to immunity. A five-group systemInt J Lepr Other Mycobact Dis19663432552735950347
- RidleyDSTherapeutic trials in leprosy using serial biopsiesLepr Rev1958291455213515393
- ZenhaEMFerreiraMAFossNTUse of anti-PGL-1 antibodies to monitor therapy regimes in leprosy patientsBraz J Med Biol Res2009421096897219784481
- Ministério da Saúde, Secretaria de Políticas de Saúde, Departamento de Atenção BásicaControle da Hanseníase Na Atenção Básica: Guia Prático Para Profissionais da Equipe de Saúde Da FamíliaLeprosy Control in Primary Care: A Practical Guide for Professionals in Family Health TeamBrasíliaMinistério da Saúde2001 Portuguese
- FossMCFossNTPaccolaGMSilvaCLSerum levels of tumor necrosis factor in insulin-dependent diabetic patientsBraz J Med Biol Res19922532392421341919
- BonatoVLDCorrelação dos Anticorpos Anti-PGL-I com o Índice Baciloscópico, a Reação De Mitsuda, o Tratamento Poliquimioterápico e as Interleucinas nas Diferentes Formas da HanseníaseCorrelation of Antibodies Ant-PGL-1 with Bacterial Index, the Mitsuda Reaction from Chemotherapy Treatment and Interleukins in Different Forms of Leprosy [Master’s thesis]São PauloUniversidade de São Paulo1995 Portuguese
- ChenZLTangQGWangZMChenJPilot study to determine acceptability and ability of heat-killed Mycobacterium leprae plus BCG (HKML + BCG) vaccine to induce skin test conversionLepr Rev19936421171278341114
- Beck-BleuminkMBerheDOccurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in EthiopiaInt J Lepr Other Mycobact Dis19926021731841522359
- ZaheerASMisraRSSharmaAKImmunotherapy with Mycobacteruim w vaccine decreases the incidence and severity of type 2 (ENL) reactionsLepr Rev19936417148464320
- SharmaPKarHKMisraRSReactional states and neuritis in multibacillary leprosy patients following MDT with/without immunotherapy with Mycobacterium w antileprosy vaccineLepr Rev200071219320510920614
- MouraRSCaladoKLOliveiraMLBührer-SékulaSLeprosy serology using PGL-1: a systematic reviewRev Soc Bras Med Trop200841Suppl 2S11S18
- MarchantAGoetghebuerTOtaMONewborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guérin vaccinationJ Immunol199916342249225510438968
- MurrayHWRubinBYRothermelCDKilling of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokineJ Clin Invest1983724150615106415111
- SielingPAModlinRLCytokine patterns at the site of mycobacterial infectionImmunobiology19941914–53783877713551
- MillsKHMcGuirkPAntigen-specific regulatory T cells – their induction and role in infectionSemin Immunol200416210711715036234
- ApteRSRegulation of angiogenesis by macrophagesAdv Exp Med Biol2010664151920237997
- Mahdavian DelavaryBvan der VeerWMvan EgmondMNiessenFBBeelenRHMacrophages in skin injury and repairImmunobiology2011216775376221281986
- GopalRLinYObermajerNIL-23-dependent IL-17 drives Th1-cell responses following Mycobacterium bovis BCG vaccinationEur J Immunol201242236437322101830
- UmemuraMYahagiAHamadaSIL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guérin infectionJ Immunol200717863786379617339477
- LiLHuangLVergisALIL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injuryJ Clin Invest2010120133134220038794
- Conti-FreitasLCFoss-FreitasMCMamedeRCFossNTEffect of BCG stimulus on proinflammatory cytokine production in laryngeal cancerCancer Immunol Immunother2009581252918421458
- SilvaCLFossNTTumor necrosis factor in leprosy patientsJ Infect Dis198915947877902926170
- CastilhoMLORCorrelação Entre BCG Intradérmico e Linfoproliferação, Produção e Expressão de Rnam das Citocinas Ifnγ, IL-12, IL-10 E IL-4, Níveis de Anti-PGL-1 em Pacientes com Hanseníase e em Seus ComunicantesCorrelation Between BCG and Lymphoproliferation, Production and mRNA Expression of Cytokines IFNg, IL-12, IL-10 and IL-4, Levels of Anti-PGL-1 in Leprosy Patients and their Contacts [Master’s thesis]São PauloUniversidade de São Paulo2001 Portuguese
- SenguptaUCell-mediated immunity in leprosy: an updateInt J Lepr Other Mycobact Dis19936134394548228444
- RadaESantaellaCAranzazuNConvitJPreliminary study of cellular immunity to Mycobacterium leprae protein in contacts and leprosy patientsInt J Lepr Other Mycobact Dis19926021891941522361
- RadaEUlrichMAranzazuNA longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapyInt J Lepr Other Mycobact Dis19946245525587868953
- RadaEUlrichMAranzazuNA follow-up study of multibacillary Hansen’s disease patients treated with multidrug therapy (MDT) or MDT + immunotherapy (IMT)Int J Lepr Other Mycobact Dis19976533203279401484